Evidence map›Paper›PMID 40250737›Full record

ArticleAmerican journal of preventive medicine2025

Effects of Cannabis Use for Medical Symptoms on Cannabis Use Disorder Symptoms: A 24-Month Follow-up Study.

Julia Jashinski, Bryn Evohr, Kevin Potter, Randi M Schuster, A Eden Evins, Jodi M Gilman

Abstract read
In one paragraph

Article in American journal of preventive medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Julia JashinskiCenter for Addiction Medicine, Department of Psychiatry, Massachusetts General Hospital, Boston, Massachusetts.
Bryn EvohrCenter for Addiction Medicine, Department of Psychiatry, Massachusetts General Hospital, Boston, Massachusetts.
Kevin PotterCenter for Addiction Medicine, Department of Psychiatry, Massachusetts General Hospital, Boston, Massachusetts; Department of Psychiatry, Harvard Medical School, Boston, Massachusetts.
Randi M SchusterCenter for Addiction Medicine, Department of Psychiatry, Massachusetts General Hospital, Boston, Massachusetts; Department of Psychiatry, Harvard Medical School, Boston, Massachusetts.
A Eden EvinsCenter for Addiction Medicine, Department of Psychiatry, Massachusetts General Hospital, Boston, Massachusetts; Department of Psychiatry, Harvard Medical School, Boston, Massachusetts.
Jodi M GilmanCenter for Addiction Medicine, Department of Psychiatry, Massachusetts General Hospital, Boston, Massachusetts; Department of Psychiatry, Harvard Medical School, Boston, Massachusetts. Electronic address: jgilman1@mgh.harvard.edu.

Funding

Medical Marijuana, Neurocognition, and Subsequent Substance UseR01DA042043 · NIDA · MASSACHUSETTS GENERAL HOSPITAL · PI GILMAN, JODI · 2017 to 2021
$3.3M
Using Neuroimaging Markers to Understand Risk Factors and Consequences of Cannabis on Brain Structure and FunctionK02DA052684 · NIDA · MASSACHUSETTS GENERAL HOSPITAL · PI GILMAN, JODI · 2021 to 2025
$642k
NIDA NIH HHS K02 DA052684NIDA NIH HHS R01 DA042043
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID40250737
PMCPMC12185228

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.